Archive

The aim of the programme was to motivate the young student community, to instil and incite creative minds to build new ventures…

The Budget doesn’t have any special announcements with respect to the pharmaceutical industry except strengthening of drug testing…

The budget fell short of expectations while the market was looking forward to some meaningful reforms. What we found instead, were…

Modi Government in its first budget has addressed the current challenges facing the Indian economy by taking key measures to…

The issues around the pharma sector are more policy related, with tax measures forming only part of the solution. While the…

The budget has drawn some broad strokes on the canvas showing the governments intent in the coming years. The budget has given…

Overall a pragmatic and balanced budget. The new government has probably tried to balance the fiscal deficit restrictions…

The budget lays a lot of emphasis on spurring growth in the manufacturing sector. The investment allowance linked to the new…

The programme combines grants portfolio with annual €20 million investment to advance innovation and medical education

Telmisartan is Glenmark’s generic version of Boehringer Ingelheim’s Micardis

{source}<div data-configid="5690019/8536578" style="width: 600px; height: 396px;" class="issuuembed"></div><script…

The investment will fund the launch of a range of drugs in the areas of respiratory, oncology and antiretroviral medicines

Public Relations Abby category, a new category of awards introduced this year

3rd FICCI Quality Systems Excellence Awards for manufacturing assess quality systems

Previously the event has been organised in London and Paris

Will be appointing Martin Shanahan to the role of Chief Executive Officer

Srinivas is an economics graduate and also holds an MBA degree

Also receives orphan product designation by the FDA because it is intended to treat a rare disease or condition

The facilities in Mumbai, Bengaluru and Hyderabad are audited according to globally defined GDP to ensure conformity across the…

GBR 830 is an antagonistic monoclonal antibody with first in class potential for the treatment of autoimmune diseases targeting…